Researchers examined 509 consecutive patients with acute leukemia admitted to a hospital between 2006 and 2017.
They found:
• Incidence of C. diff was 2.2 per 1,000 inpatient days during induction therapy.
• C. diff was rare after hospital discharge.
• C. diff was highest in patients with acute myelogenous leukemia.
• A hospitalization shortly before admission and administration of a higher number of antibiotics increased the risk for C. diff.
• No single class of antibiotics conveyed an increased risk.
The researchers also found all cases were successfully treated, and C. diff was not associated with an increase in length of stay, costs or mortality.
More articles on healthcare quality:
AHA weighs in on proposed star ratings changes: 4 things to know
Stop calling physicians ‘second victim’ of medical errors, patient advocates say
26 states still report high flu activity: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
